OBJECTIVE: Pleural tuberculosis is the most frequently occurring form of extra pulmonary disease in adults. In up to 40% of cases, the lung parenchyma is concomitantly involved, which can have an epidemiological impact. This study aims to evaluate the pleural and systemic inflammatory response of patients with pleural or pleuropulmonary tuberculosis.
INTRODUCTION
Pleural tuberculosis is the most common extra pulmonary form of tuberculosis in adults, particularly in countries where the prevalence of the disease is high or moderate (1) (2) (3) . Although pulmonary tuberculosis can be a manifestation of primary infection, it is most commonly associated with the reactivation of pre-existing foci (1, 2, 4) . It is generally accepted that pleural tuberculosis results from a late hypersensitive reaction to the antigens of M. tuberculosis subsequent to the rupture of a subpleural caseous focus (1, 2, 4) . The release of even a small number of bacilli from the lungs to the pleural space triggers a series of immune reactions that are mediated by T lymphocytes, which produce cytokines and stimulate macrophages to form a granuloma (4) (5) (6) (7) . These events trigger an inflammatory process in the pleural cavity: vascular permeability increases and an influx of leukocytes enter the pleural space, resulting in the accumulation of fluid and cells, which is a characteristic of the pleural exudates (1, 2, 6) .
Cytokines are a group of polypeptides with multiple biological functions that act with other inflammatory mediators to coordinate the interaction between sensitized lymphocytes and macrophages to form granulomas (5) (6) (7) (8) (9) (10) (11) . Among the involved mediators, we highlight the importance of interleukin-8 (IL-8) (8) (9) (10) (11) (12) (13) (14) (15) , vascular endothelium growth factor (VEGF) (8, 9, (16) (17) (18) , tumor necrosis factor-a (TNF-a) (8, 9, 11, (17) (18) (19) (20) , and transforming growth factor-b 1 (TGF-b 1 ) (7, 9, 20, 21) , all of which are considered to be key effectors in the inflammatory response of the pleural space (4) (5) (6) .
Although pleural and pulmonary lesions were previously considered to be independent events, the advent of computed tomography has demonstrated concomitant lesions in more than 40% of cases (1, (21) (22) (23) (24) . This concomitance may have an epidemiological impact, given that many patients with pleural tuberculosis are not adequately evaluated for intrathoracic involvement. This finding enables us to speculate whether serum or pleural fluid inflammatory markers in pleural tuberculosis could suggest associated active pulmonary disease. The answer to this question is particularly relevant if we consider the potential risk of Mycobacterium tuberculosis transmission from these patients to contacts.
Therefore, this study compares the serum and pleural fluid expression of inflammatory mediators in pleural tuberculosis patients to evaluate whether pulmonary-associated involvement influences the magnitude of the inflammatory response. We hypothesized that the more extensive the injury, the greater the inflammatory response. If this hypothesis is true, the inflammatory cytokines could be increased both locally (pleural fluid) and in the serum as a result of the pulmonary involvement.
METHODS
After approval by the local ethics committee, informed consent was obtained from 39 pleural tuberculosis patients. The patients were prospectively selected from the outpatient clinic of Pulmonary Diseases (InCor/FMUSP), Sã o Paulo, Brazil.
The diagnosis of pleural tuberculosis was based on the presence of a granuloma (upon pleural biopsy) associated with exudative effusion with increased adenosine deaminase (ADA . 40 IU/L) and/or a culture of the pleural fluid or fragment positive for Mycobacterium tuberculosis (1, 2, 25) . After thoracentesis, the patients underwent high resolution chest tomography (HRCT) and were subdivided into two groups based on the HRCT findings: pleuropulmonary (n = 19) or only pleural involvement (n = 20). The tomographic abnormalities that were suggestive of active pulmonary disease included the following: multi-segmental consolidation over the upper lung zones (homogenous opacity that reflected granulomatous inflammation of the parenchyma), thickwalled cavities (resulting from the coalescence of multiple inflammatory foci that necrotized and drained into the airways), centrilobular or confluent nodules, and the presence of the tree-in-bud pattern, which reflects the endobronchial dissemination of caseous necrosis and the granulomatous inflammation that fills and surrounds the alveolar ducts and respiratory bronchioli. Patients who had nonspecific tomographic findings or images of residual scarring were not included in this series (23) (24) (25) . HIV patients, patients previously treated for tuberculosis, and patients undergoing immunosuppressant therapy were also excluded.
Concomitant with thoracentesis, all of the patients underwent peripheral venous puncture and tuberculin skin tests. Pleural fluid samples were processed for cytology, bacilloscopy, M. tuberculosis cultures, and to determine the adenosine deaminase levels (Giusti modified method) (26) . Proteins (Biuret method) and lactic dehydrogenase (enzymatic method) were also quantified in the blood and pleural fluid. Aliquots from both samples (serum and pleural fluid) were immediately centrifuged (1,500 rpm for 10 minutes at 4˚C), and the supernatant was stored at -80˚C for posterior cytokine analyses.
VEGF, IL-8, TNF-a, and TGF-b 1 were quantified using an immunoenzymatic method (enzyme-linked immunosorbent assay, ELISA) according to the manufacturer's instructions (R&D Systems Inc., Minneapolis, USA). The assays were performed in triplicate, and the results are expressed as means. The results were quantified by comparing the optic density (450 nm filter) in the ELISA reader (Powerwave, Biotek, USA) against a pre-established standard curve. The minimal detection values for IL-8, VEGF, and TGF-b 1 were 31 pg/mL, and the minimum detection value for TNF-a was 16 pg/mL. To evaluate the pleural inflammatory response, the results were compared with those obtained from the serum and pleural fluid of the patients with transudates that were caused by heart failure (27) .
Statistical analysis
The results of the inflammatory marker analysis were compared using Student's T-test or the Mann Whitney Utest according to the distribution of the variables. The 25 th -75 th ); p#0.05 was considered to be statistically significant.
RESULTS
Thirty-nine patients (35¡15 years) presented with pleural effusions caused by tuberculosis, and 19 patients exhibited concomitant parenchyma involvement. In the patients with pleural effusion (n = 20), the detection of fast acid bacilli in the sputum was negative. In the pleuropulmonary group (n = 19), three patients exhibited positive fast acid bacilli in sputum. In two patients in the pleural group and six patients in the pleuropulmonary group, the response to the skin test exhibited indurations that were greater than 5 mm. Thus, the microbiological detection and the skin test contributed little toward diagnosing active pulmonary tuberculosis. The patients were not submitted to bronchoalveolar lavage because they had previously been diagnosed with pleural tuberculosis.
The HRCT findings that were considered to be suggestive of active pulmonary disease met the following criteria: the presence of centrilobular nodules (n = 14), confluent nodules (n = 11), tree-in-bud pattern (n = 15), pulmonary consolidation in the upper lung zones (n = 8), and thick-walled cavities (n = 3). Some patients exhibited more than one of these radiological changes.
Tuberculous pleural effusions were exudates with high ADA levels according to Light's criteria. Comparing with transudates, the levels of all inflammatory markers were higher in the pleural fluid of the tuberculosis patients (data not shown). VEGF and TGF-b1 were increased to similar levels in the blood and pleural fluid of the patients with both forms of the disease. The TNF-a levels were significantly higher in the pleural fluid of the patients with the pleuropulmonary form of the disease; this difference represented the single parameter that was capable of differentiating between the two forms. IL-8 was increased in the pleural fluid of all the TB patients, and no differences in the levels of IL-8 were observed between the two forms. As expected, the protein and lactic dehydrogenase levels were higher in the serum and pleural fluid, respectively (Table 1 ; Figures 1 and 2 ).
DISCUSSION
The high expression of inflammatory mediators in the pleural fluid of pleural tuberculosis patients allows us to recognize the exudative inflammatory response at the site of active disease. The increased levels of VEGF and TGF-b in the serum of these patients reflect the systemic response observed in cases of pleural tuberculosis. Although elevated TNF-a levels in the pleural fluid was the single parameter that was capable of differentiating between the two forms of the disease, the overlapping results do not suggest that this cytokine is a marker of pulmonary involvement. Tuberculosis pleurisy is an acute and symptomatic disease that invariably evolves with exudative pleural effusions that are rich in cells and inflammatory mediators (1,2,4,7-10). Although tuberculosis pleurisy can indicate a manifestation of primary infection, it is most commonly associated with the reactivation of preexisting foci (1,2,4) . Currently available laboratory methods frequently fail to demonstrate a possible concomitance with active pulmonary disease (1) . In this regard, high resolution chest tomography has been helpful in identifying pulmonary lesions that are consistent with active disease in approximately 40% of pleural tuberculosis patients (20) (21) (22) (23) (24) . This finding has epidemiological implications, particularly if we consider that these patients are potential sources of infection and that their contacts are often not clinically or radiologically evaluated. Therefore, we hypothesized that the patients with the pleuropulmonary form of tuberculosis could exhibit a greater inflammatory response because of the involvement of more than one anatomic site. This fact presumably determines systemic repercussions that could be detected by evaluating the serum and pleural inflammatory mediators. Our findings corroborate previously described reports of increased inflammatory mediators in the pleural fluid of patients with pleural tuberculosis, thereby providing evidence of the compartmentalization of the inflammatory response at the active disease site (10, 13, 20, 27) . During the early phases of infection, after antigenic stimulation is triggered by the mycobacteria, cytokines such as VEGF, TNF-a, and IL-8 are transiently produced in vivo and alter the pleura permeability; this event precedes the exudative phase (20, 28) . However, the elevated serum levels of TNF-a and TGF-b are thought to be related to prolonged antigenic stimulation, similar to observations in patients with pulmonary tuberculosis or late-diagnosed pleural tuberculosis (28) (29) (30) .
In pleural tuberculosis, many cytokines are produced intracavitarially and modulate the inflammatory response that is triggered by the mycobacteria or its antigens to limit or aggravate the disease (7, 19) . Previous studies have related the findings of high serum or PF levels of TNF-a, TGF-b, and IL-8 to residual pleural thickening (19, 20) . TGFb is a mediator that is expressed in active infection and plays a fundamental role in the fibrotic scaring process. TGF-b is a key mediator in the immunopathogenesis of tuberculosis because it is able to modify the production and function of other cytokines, such as IL-1b and TNF-a, in addition to modulating the functions of T lymphocytes and macrophages (7, 20, 29, 30) . In pleural tuberculosis, the excessive production of TGF-b is believed to be related to the clinical progression of the disease, particularly in the physiopathology of pleural thickening (29) . TGF-b possesses proinflammatory activity in low concentrations (pleural tuberculosis and healthy contacts of tuberculosis carries) and antiinflammatory activity in high concentrations (pulmonary tuberculosis). We observed increased levels of TGF-b in the pleural fluid and blood of tuberculosis patients. Although higher TGF-b levels were observed in the pleuropulmonary form, there was no statistical significance when compared to the levels in patients with pleural disease. Siawaya et al. (8) studied the cytokine and chemokine profiles of patients with different forms of tuberculosis to better understand the immunopathology of the disease and identify the biological markers that differentiate the various clinical forms of the disease. The authors concluded that systemic inflammatory markers, such as IL-8, TNF-a, and VEGF, are associated with pleural tuberculosis, whereas elevated levels of the factors involved in cell-mediated immunity, such as IL-12p40 and sCD40L, characterize pulmonary tuberculosis.
In conclusion, the present study demonstrates an intense intracavitary inflammatory response in the patients with pleural tuberculosis independent of parenchymal involvement. Although all of the cytokines were overexpressed in the pleural fluid, only TNF-a was significantly increased in the pleuropulmonary tuberculosis patients. This finding could suggest a more pronounced inflammatory response because of the concomitance of the anatomic sites involved. However, TNF-a should not be considered to be a biological marker of pulmonary-associated disease. Although HRCT can be useful in identifying these patients, the identification of fast acid bacilli and/or the culture for M. tuberculosis in the sputum is recommended for all pleural tuberculosis patients.
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